Monica Prokocki
Vice President of Finance and Investor Relations
Replay available
LifeStance Health Group, Inc. (NASDAQ: LFST) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Vice President of Finance and Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Morgan Stanley
Analyst, JP Morgan
Analyst, William Blair
Analyst, Jefferies LLC
Analyst, UBS
Analyst, Canaccord Genuity
Analyst, BTIG
Analyst
Analyst, KeyBank
Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to LifeSense Health Second Quarter 2026 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. We do request for today's session that you please limit to one question and one follow-up only. If you would like to ask a question during this time, Simply press star, then the number one on your telephone keypad. To withdraw your question, press star one again. I would now like to turn the conference over to Monica Prokocki. You may begin. Thank you, operator. Good morning, everyone, and welcome to LifeSense Health's second quarter 2026 earnings conference call. I'm Monica Prokocki, Vice President of Finance and Investor Relations. Joining me today are Dave Bourdon, Chief Executive Officer, and Ryan McGroarty, Chief Financial Officer. We issued the earnings release and presentation before the market opened this morning. Both are available on the investor relations section of our website, investor.lifestance.com. In addition, a replay will be available following the call. Before turning over to management for their prepared remarks, Please direct your attention to the disclaimers about forward-looking statements included in the earnings press release and SEC filings. Today's remarks contain forward-looking statements including statements about our financial performance outlook, business model, and strategy. Those statements involve risks, uncertainties, and other factors, as noted in our periodic filings with the SEC, that could cause actual results to differ materially. Please note that we report results using non-GAAP financ...